Nabulsi Azmi 4
4 · Phathom Pharmaceuticals, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-07-15$11.72/sh−10,901$127,760→ 240,421 total
Holdings
- 785,700(indirect: By Trust)
Common Stock
- 3,578.93(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan